The LUMIstar OMEGA is a compact, modular luminescence microplate reader that is designed for the widest possible range of applications based on luminescence detection such as luciferases, Renilla, DLR, and aequorin.
The LUMIstar Omega is a highly sensitive luminescence microplate reader for flash and glow luminescence assays including:
• Luciferase reporter gene assays, promoter analysis • Luminescent immunoassays • Cell-based assays and viability • Intracellular Ca2+ with aequorin • Ion channel, GPCR screening • ATP assays • GUS assays (ß-glucuronidase) • ROS (reactive oxygen species) • BRET assay for monitoring intermolecular interactions • Enzyme activity assays (e.g. evaluation of PARP inhibitors, screen for cytochrome P450 inhibitors, protein kinase assay) • Nucleic acid detection (PCR quantification)
Additional features Through onboard reagent injectors the LUMIstar Omega offers point of measurement injection for initiating fast kinetic events. Other outstanding features include a built-in filter wheel for color discrimination assays, shaking, incubation up to 45°C or even 65°C and much more. Simultaneous Dual Emission detection is also available for BRET applications.
Gas Control Capabilities Using a proprietary Atmospheric Control Unit (ACU), the LUMIstar Omega independently controls both the O2 (1-19%) and CO2 (0-20%) gas concentrations within the microplate reader chamber. Upgradeable to multimode microplate reader with spectrometer The LUMIstar Omega microplate luminometer can be upgraded to include fluorescence intensity and time-resolved fluorescence measurement capabilities (the FLUOstar Omega multimode microplate reader). The LUMIstar Omega can also be upgraded to include fluorescence polarization (POLARstar Omega) as well as ultra-fast, full spectrum absorbance (SPECTROstar Omega).
Stacker and robot compatibility For medium level throughput, the LUMIstar Omega can be equipped with a 50 plate Stacker with optional bar code reader. For even higher throughput, the LUMIstar Omega can be integrated into all existing robotic systems via DDE or ActiveX interface.
Software package The LUMIstar Omega license-free software includes the Omega Reader Control and the MARS Data Analysis software. This highly intuitive software provides limitless possibilities for test set-up and data analysis, while also offering one-click, app-style application shortcuts for running routine tests and data analyses. One click calculations include percent CVs, standard deviations, Z' value, Lineweaver-Burk plots, IC-50/EC-50, DNA quantitation, and enzyme kinetic calculations including Michaelis-Menten
Charting Kidney Cancer Metabolism Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.Insights into the Function of the Main Class of Drug Targets About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.Visualizing a Cancer Drug Target at Atomic Resolution Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.Honey’s Potential to Save Lives The healing powers of honey have been known for thousands of years. 3-D Printed Lifelike Liver Tissue for Drug Screening A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling. Cytoskeleton Crew Findings confirm sugar's role in helping cancers survive by changing cellular architecture.Biomarker for Recurring HPV-Linked Oropharyngeal Cancers A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University. Valvena, GSK Sign New R&D Collaboration Valneva to supply process development services for EB66® -based Influenza vaccines. Light Signals from Living Cells Fluorescent protein markers delivered under high pressure.Cellular 'Relief Valve' A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.